The aim of this article is to provide an overview of the European regulatory environment and to outline some of the main pharmaceutical regulations and requirements for companies to consider when bringing a new medicinal product to the European market. Graham Donaldson, Regulatory Affairs Project Manager for TRAC Services, explains.
https://international-pharma.com/wp-content/uploads/2015/06/Obtaining…pdf.pdf
Current Edition
Current Edition
Subsection - CDMO
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingSubsection - Injectables
Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingSubsection - Neurodegenerative Diseases
Exploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingSubsection - Nasal & Pulmonary
Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue reading
Obtaining European Regulator y Approval – Graham Donaldson, TRAC Services
